Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis.

Front Med (Lausanne) · 2026 · PMC13293795 · PMID 42369158

Europe PMC DOI

hedged sentences

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

did not reach statistical significanceP = 0.076so close (0.05 < p ≤ 0.1)

The model explained 15.64% of the total between-study variance, although the overall omnibus test did not reach statistical significance [ F (14, 48) = 1.75, P = 0.076].

also in 111,027 other papers

showed a trendno p-value reported

North American region showed a trend toward higher risk, though this did not reach statistical significance (coefficient = 1.1201, P = 0.0586).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.